Pharmacologic Considerations in the Management of Patients Receiving Left Ventricular Percutaneous Mechanical Circulatory Support.

about

Pharmacologic Considerations in the Management of Patients Receiving Left Ventricular Percutaneous Mechanical Circulatory Support.

Item

http://www.wikidata.org/entity/Q39457136

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pharmacologic Considerations i ...... echanical Circulatory Support.

@en

Pharmacologic Considerations i ...... echanical Circulatory Support.

@nl

type

Item

label

Pharmacologic Considerations i ...... echanical Circulatory Support.

@en

Pharmacologic Considerations i ...... echanical Circulatory Support.

@nl

prefLabel

Pharmacologic Considerations i ...... echanical Circulatory Support.

@en

Pharmacologic Considerations i ...... echanical Circulatory Support.

@nl

P1476

Pharmacologic Considerations i ...... Mechanical Circulatory Support

@en

P2093

Carrie S Oliphant

http://www.w3.org/2001/XMLSchema#string

Douglas L Jennings

http://www.w3.org/2001/XMLSchema#string

J Erin Allender

http://www.w3.org/2001/XMLSchema#string

Jenna L Foster

http://www.w3.org/2001/XMLSchema#string

Jeremy D Moretz

http://www.w3.org/2001/XMLSchema#string

Robert J DiDomenico

http://www.w3.org/2001/XMLSchema#string

P2860

Impella ventricular support in clinical practice: Collaborative viewpoint from a European expert user group

2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

Mechanical circulatory support in cardiogenic shock.

Heparin-induced thrombocytopenia in left ventricular assist device bridge-to-transplant patients.

Use of an argatroban-based purge solution in a percutaneous ventricular assist device.

The current use of Impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the USpella Registry

A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction.

Is heparin needed for patients with an intra-aortic balloon pump?

Decade-Long Trends (2001-2011) in the Incidence and Hospital Death Rates Associated with the In-Hospital Development of Cardiogenic Shock after Acute Myocardial Infarction

Techniques and complications of TandemHeart ventricular assist device insertion during cardiac procedures.

P304

1272-1283

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/PHAR.1995

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Brent N Reed

James C Coons

P577

2017-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28741848

http://www.w3.org/2001/XMLSchema#string